Latest Food & Drug Administration news
Dr. Richard Pazdur Appointed to Lead FDA”s Drug Division After Turbulent Year
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Lifts Major Warnings on Hormone Replacement Therapy
posted November 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Top FDA Drug Chief Resigns While Under Investigation
posted November 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tezspire for Chronic Rhinosinusitis With Nasal Polyps
posted October 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Full, Limited Functional Endoscopic Sinus Surgery Beneficial in Rhinosinusitis With Nasal Polyps 
One-Third of Patients With Chronic Rhinosinusitis With Nasal Polyps Exhibit Anxiety Symptoms 
No Association Seen for Menopause With Chronic Rhinosinusitis 
GLP-1 Receptor Agonists Tied to Lower Revision Rate After Functional Endoscopic Sinus Surgery 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
